Steven A. Pergam, MD, MPH
Specialty: Infectious Disease
Even with vaccines and antivirals, cancer patients and many others are still vulnerable to infection; some safety tips for this evolving pandemic
Seattle Cancer Care Alliance (SCCA) leaders responded to the COVID-19 outbreak with unprecedented speed, thoughtful consideration and collaboration. Rapidly established COVID-19 infection prevention protocols allowed our staff to provide compassionate care while protecting our patients from the pandemic
We make promising new treatments available to you through studies called clinical trials led by Fred Hutch doctors. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our Fred Hutch doctors conduct ongoing research to improve standards of patient care. Their work is evaluated by other doctors and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch provider has written.
Our providers are often asked to give their medical expertise for press and news publications. Read articles by or about this Fred Hutch provider.
SCCA’s Steven Pergam, MD, MPH, was featured in AJMC discussing NCCN’s preference for mRNA vaccines in patients with cancer to prevent COVID-19.
SCCA’s Dr. Steven Pergam spoke with The American Journal of Managed Care (AJMC) about the National Comprehensive Cancer Network (NCCN) update on COVID-19 vaccines and prevention.
Your care team
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.